NCT00485563 2012-03-08A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell CarcinomaEndocytePhase 2 Terminated12 enrolled
NCT00393029 2011-08-15Phase II Study of Metastatic Cancer That Overexpresses P53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-P53 TCR-Gene Engineered LymphocytesNational Institutes of Health Clinical Center (CC)Phase 2 Completed12 enrolled 10 charts